The Intersection of Oncology Care and Worker Well-Being
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT05250284
- Status
- Recruiting
Conditions
- Solid Tumor
Eligibility Criteria
- Sex
- MALE
- Age
- 21 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- WellBQ — BEHAVIORALNational Institue for Occupational Safety and Health Worker Well-Being Questionnaire is comprised of 21 scales (multiple items assessing a single construct) and 31 single items that cover worker well-being. Domains include (i) work evaluation and experience, (ii) workplace policies and culture, (iii) workplace physical environment and safety climate, (iv) health status, and (v) home, community, and society.
- PROMIS — BEHAVIORALPatient-Reported Outcomes Measurement Information System is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children.
Study Details
The goals of this study will be a greater understanding of cancer patients' well-being experience through the care/treatment continuum. An important aspect of the study is an understanding of work- and treatment-related challenges experienced by low-income men, many of whom will be Latino. At the 12-month observation period, the investigators will learn whether these men work long-term and how work status relates to well-being.
Key Dates
- Start date
- Apr 4, 2022
- Status verified
- Nov 2025
- Primary completion
- May 31, 2026
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 400 participants (estimated)
Primary Outcome Measure
Employment Hours Worked [ Time Frame: 2 years ]
Central Contacts
- Carol Brown, PhD562.587.9123
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | Carol Brown Carol E Brown (SUB_INVESTIGATOR) Lee S Newman (SUB_INVESTIGATOR) Liliana Tenney (SUB_INVESTIGATOR) Brian D Williams (SUB_INVESTIGATOR) |
Find similar trials in Aurora, CO
By research site
Related Studies
- A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Aurora, Colorado
- A Study of Azenosertib (ZN-c3) in Patients With Ovarian CancerPHASE1 · Recruiting · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc · Aurora, Colorado
- Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067PHASE1/PHASE2 · Recruiting · Simcha IL-18, Inc. · Scottsdale, Arizona
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPHASE1 · Recruiting · I-Mab Biopharma US Limited · Orange, California